Skip to main content
SpringerLink
Log in

Stability of Gonadorelin and Triptorelin in Aqueous Solution

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

The influence of pH, temperature, various buffer species at different concentrations, and ionic strength on the stability of gonadorelin and triptorelin in aqueous solution has been studied using stability-indicating high-performance liquid chromatographic methods. The degradation behavior of both peptides is similar. The maximum stability of both peptides was shown to be at an approximate pH of 5.0. Acetate has the most favorable effect on stability, while phosphate causes higher degradation. Varying the concentration of acetate buffer does not affect the degradation behavior of the peptides. A higher phosphate concentration in buffer solutions causes higher degradation, however. The ionic strength of buffer solutions has no significant influence on stability. Solutions of gonadorelin and triptorelin, respectively, buffered with acetate (0.1 M, pH 5.0) with 3% (w/v) mannitol as an additive show a predicted t 90% of 9.0 years and 7.7 years at 20°C, respectively.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. A. V. Schally, A. Arimura, Y. Baba, R. M. G. Nair, H. Matsuo, T. W. Redding, L. Debeljuk, and W. F. White. Isolation and properties of the FSH and LH-releasing-hormone. Biochem. Biphys. Res. Commun. 43:393–399 (1971).

    Google Scholar 

  2. D. H. Coy, J. A. Vilchez-Martinez, E. J. Coy, and A. V. Schally. Analogs of luteinizing hormone-releasing hormone with increased biological activity produced by D-amino acid substitutions in position 6. J. Med. Chem. 19:423–425 (1976).

    Google Scholar 

  3. G. Forti. Clinical applications of GnRH analogs. J. Endocrinol. Invest. 11:745–754 (1988).

    Google Scholar 

  4. B. J. Furr and J. R. Woodburn. Luteinizing hormone-releasing hormone and its analogues: A review of biological properties and clinical uses. J. Endocrinol. Invest. 11:535–557 (1988).

    Google Scholar 

  5. R. N. Clayton. Gonadotrophin releasing hormone: From physiology to pharmacology. Clin. Endocrinol. 26:361–384 (1987).

    Google Scholar 

  6. R. J. Santen and J.-P. Bourguignon. Gonadotropin-releasing hormone: Physiological and therapeutic aspects, agonists and antagonists. Hormone Res. 28:88–103 (1987).

    Google Scholar 

  7. A. K. Banga and Y. W. Chien. Systemic delivery of therapeutic peptides and proteins. Int. J. Pharm. 48:15–50 (1988).

    Google Scholar 

  8. H. J. Roth. Polypeptide als Arzneistoffe. Dtsch. Apoth. Ztg. 128:1085–1102 (1988).

    Google Scholar 

  9. P. M. Hahn, D. A. Van Vugt, and R. L. Reid. The stability of synthetic gonadotropin-releasing hormone in solution. Fertil. Steril. 48:155–158 (1987).

    Google Scholar 

  10. D. M. Johnson, R. A. Pritchard, W. F. Taylor, D. Conley, G. Zuniga, and K. G. McGreevy. Degradation of the LH-RH analog nafarelin acetate in aqueous solution. Int. J. Pharm. 31:125–129 (1986).

    Google Scholar 

  11. Y.-F. Shi, R. J. Sherins, D. Brightwell, J. F. Galleli, and D. C. Chatterji. Long-term stability of aqueous solutions of luteinizing hormone-releasing hormone assessed by an in vitro bioassay and liquid chromatography. J. Pharm. Sci. 73:818–821 (1984).

    Google Scholar 

  12. J. Winterer, D. Chatterji, F. Comite, M. H. Decker, D. L. Loriaux, J. F. Galleli, and G. B. Cutler, Jr. Thermal stability of a long-acting analogue of luteinizing hormone-releasing hormone (D-Trp6-Pro9-Net-LHRH). Contraception 27:195–200 (1983).

    Google Scholar 

  13. D. C. Sertl, R. N. Johnson, and B. T. Kho. An accurate, specific HPLC method for the analysis of a decapeptide in a lactose matrix. J. Liq. Chromatogr. 4:1135–1156 (1981).

    Google Scholar 

  14. K. Nishi H, Ito, S. Shinagawa, C. Hatanaka, M. Fujino, and M. Hattori. In H. Yonehara (ed.), Peptide Chemistry 1979, Protein Research Foundation, Osaka, 1980, pp. 175–180.

    Google Scholar 

  15. J. Sandow, E. Vogl, and W. Bogie. Effect of storage on LH-RH. N. Engl. J. Med. 296:885 (1977).

    Google Scholar 

  16. W. C. Dermody and J. R. Reel. Effect of storage on LH-RH. N. Engl. J. Med. 295:173 (1976).

    Google Scholar 

  17. E. Debesis, J. P. Boehlert, T. E. Givand, and J. C. Sheridan. Submitting HPLC methods to the compendia and regulatory agencies. Pharm. Techn. 6:120–137 (1982).

    Google Scholar 

  18. J. W. van Nispen. In D. D. Breimer and P. Speiser (eds.), Topics in Pharmaceutical Sciences 1987, Elsevier Science, Amsterdam, 1987, pp. 293–307.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Analytical Division, Ferring Arzneimittel, Kiel, Germany

    Volker J. Helm

  2. Department of Pharmacy, Christian-Albrechts-Universität, Kiel, Germany

    Bernd W. Müller

Authors
  1. Volker J. Helm
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bernd W. Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Helm, V.J., Müller, B.W. Stability of Gonadorelin and Triptorelin in Aqueous Solution. Pharm Res 7, 1253–1256 (1990). https://doi.org/10.1023/A:1015981704133

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1015981704133

Search

Navigation